Final September, throughout a memorably weird press convention, President Trump informed pregnant ladies—repeatedly and emphatically—to not take Tylenol. His well being secretary, Robert F. Kennedy Jr., pointed to research that “recommend a possible affiliation” between acetaminophen use throughout being pregnant and neurodevelopmental issues. Kennedy was extra adamant on The Joe Rogan Expertise just lately, insisting that he had learn 76 research on the topic over one weekend and concluded that the “science is basically clear” in exhibiting a hyperlink between the drug and the circumstances.
The science, the truth is, is in no way clear. Though some research have certainly discovered an affiliation between prenatal acetaminophen use and autism or ADHD, others haven’t, together with a current systematic evaluation of 43 research. However a brand new examine, carried out in Taiwan and revealed at the moment in JAMA Pediatrics, appears poised to inflame the controversy anew.
Kennedy’s assured assertions apart, the FDA has provided a extra evenhanded evaluation of prior proof. On the day of the September press convention, the company issued a discover to docs acknowledging that “a causal relationship has not been established” between prenatal acetaminophen use and neurological circumstances. That’s precisely proper. The research which have discovered an affiliation are usually small and unable to find out causality or rule out different potential causes. Two current giant research—one carried out in Japan, the opposite in Sweden—examined siblings and located no affiliation between acetaminophen and autism. Such research, widespread in epidemiology, examine siblings in the identical household, making use of the similarities of their genetics and atmosphere to assist rule these out as culprits. The Swedish researchers, for instance, discovered a weak affiliation between acetaminophen and neurological issues amongst all 2.4 million youngsters within the examine. However when the examine was narrowed simply to siblings, evaluating, as an illustration, one who was uncovered prenatally and one who was not, the affiliation vanished, suggesting {that a} issue apart from acetaminophen use was at play. The Japanese outcomes adopted an identical sample.
At first look, the brand new Taiwanese examine seems to reflect the conclusions of the Swedish and Japanese research. The researchers analyzed the well being data of greater than 2 million youngsters born from 2004 to 2015, together with their moms. Throughout your complete examine, moms who have been prescribed acetaminophen throughout being pregnant have been extra seemingly to offer beginning to a toddler who would later be recognized with autism or ADHD. (In Taiwan, most acetaminophen is taken by prescription, the examine’s authors recommend.) And, as within the Swedish and Japanese research, the obvious affiliation between acetaminophen and the neurological issues disappeared when the evaluation was narrowed to look solely at siblings.
However the researchers conducting the Taiwan examine additionally discovered one thing bizarre. When solely an older sibling was uncovered to acetaminophen throughout being pregnant, that youngster was extra seemingly than the youthful, unexposed sibling to have ADHD or autism. When solely a youthful sibling was uncovered, the chance for that youngster decreased. In different phrases, the siblings didn’t seem like performing as dependable controls for one another within the experiment, as can be anticipated.
It’s a head-scratching consequence, and even the authors don’t appear to have an evidence for it. (Zeyan Liew and Pei-Chen Lee, who’re listed because the examine’s corresponding authors, didn’t reply to my requests for remark.) Within the paper, they argue that their findings solid doubt on the validity of sibling research extra typically, together with their very own, arguing that the examine design may by chance introduce unexplained biases and that the households included may not be a consultant pattern of the overall inhabitants. Their skepticism of sibling research runs counter to the long-established notion that the extra slim strategy is extra rigorous, nevertheless it does appear to help Kennedy’s dismissal of the various research that point out acetaminophen’s security. Late final month, Kennedy informed Rogan that such research “have big holes in them.” (He didn’t specify what these holes is likely to be; Andrew Nixon, a spokesperson for the Division of Well being and Human Providers, didn’t make clear once I requested him.)
To attempt to make sense of the findings, I spoke with Viktor Ahlqvist, an writer of the Swedish sibling examine. Ahlqvist thought the brand new examine’s outcomes have been broadly constant along with his personal and was perplexed by the researchers’ emphasis on what appeared to him like a “native quirk,” maybe associated to some unknown variable that’s particular to Taiwan. (For example, a mom in Taiwan who’s extra seemingly to make use of acetaminophen in a primary being pregnant is likely to be totally different from different moms in different methods as nicely.) Moreover, Ahlqvist mentioned, the oddity within the Taiwanese knowledge doesn’t invalidate the general outcomes of the Swedish or the Japanese research—or of the Taiwanese examine itself, for that matter. Yusuke Okubo, a co-author of the Japanese sibling examine, was extra cautious. He informed me that though the brand new examine principally confirmed his analysis, the discrepancy between the outcomes for older and youthful siblings “means that unaddressed biases may stay.” Ruling out any potential hurt primarily based solely on siblings research like his personal is due to this fact untimely, he mentioned.
And so the science stays simply as inconclusive because it was again in September. Since then, a number of of the administration’s acetaminophen-related guarantees appear to have fallen by the wayside. Kennedy mentioned on the time that the FDA would begin the method of updating acetaminophen’s label to point the attainable dangers throughout being pregnant; in an electronic mail, a spokesperson for Kenvue, which makes Tylenol, mentioned the FDA has but to contact the corporate about that proposed change. (“We imagine that there isn’t any credible knowledge that reveals a confirmed hyperlink between taking acetaminophen and autism,” the spokesperson wrote.) The secretary additionally teased “a nationwide public-service marketing campaign to tell households” in regards to the alleged risks of prenatal acetaminophen use; if such a marketing campaign has begun, it has gone below the radar.
Again within the fall, the FDA did advise docs to think about minimizing using acetaminophen for low-grade fevers in being pregnant, although the discover additionally appropriately acknowledged that the drug is safer for pregnant ladies than aspirin or ibuprofen. A current evaluation in The Lancet discovered that, within the weeks following the White Home press convention, prescriptions for acetaminophen given to pregnant ladies who visited emergency rooms dropped as a lot as 20 p.c under what would in any other case have been anticipated; after 11 weeks, prescription charges have been approaching typical ranges once more. (Nixon didn’t reply to questions in regards to the label change or the nationwide marketing campaign, however did level me to an X publish in regards to the Lancet knowledge, wherein he wrote, “Delivering a message a couple of particular neurological danger for infants is one other instance of our dedication to telling the reality about public well being.”)
Final spring, Kennedy promised that the well being division would determine, in only a few months, not solely what has brought on autism charges to rise in the USA, but in addition stop children from being uncovered to no matter it’s. This proposal was unlikely, if not absurd. Autism researchers have been making an attempt for many years to grasp the advanced dysfunction, and the consensus amongst them is that the rise can largely be attributed to broader diagnostic standards and higher surveillance. However pinning the blame on acetaminophen, even when the case has at all times been weak, allowed the Trump administration to look to fulfill its self-imposed deadline. That affiliation, no less than, is evident.
